rhIL-2 (recombinant human interleukin-2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhIL-2 (recombinant human interleukin-2), covering 2023-08-14 to 2023-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes [Phase 2]